Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration

Takeshi Kawauchi1, Kaori Chihama, Yo-ichi Nabeshima

  • 1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.

Nature Cell Biology
|December 13, 2005
PubMed

Insights

The Cdk5-p27 pathway regulates neuronal migration by stabilizing p27 (kip1) in post-mitotic neurons. This pathway is crucial for cytoskeletal reorganization and cell movement during brain development.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Developmental Biology

Background:

  • p27(kip1) is a cyclin-dependent kinase (CDK) inhibitor (CKI) that typically inhibits CDK activity in proliferating cells.
  • The role of p27 in cell migration is not well understood, as p27-deficient mice lack obvious migration-related phenotypes.

Purpose of the Study:

  • To investigate the physiological role of p27 in neuronal migration.
  • To elucidate the regulatory relationship between CDK and CKI in G0-arrested cells.

Main Methods:

  • In vivo RNA interference (RNAi) to reduce p27 levels in neurons.
  • Analysis of F-actin content in migrating neurons.
  • Investigation of the Cdk5-p27 pathway and its effect on cofilin.

Main Results:

  • Cdk5 phosphorylates and stabilizes p27 in post-mitotic neurons.
  • Reduced p27 inhibits cortical neuronal migration and decreases F-actin in neuronal processes.
  • The Cdk5-p27 pathway activates cofilin, an actin-binding protein involved in neuronal migration.

Conclusions:

  • A novel CDK-CKI pathway involving Cdk5 and p27 regulates cytoskeletal dynamics and neuronal migration during corticogenesis.
  • This pathway is essential for maintaining p27 levels in G0-arrested neurons, impacting their migratory behavior.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...